NuVasive (NSDQ:NUVA) today announced the results of a study that showed its Cohere porous polyetheretherketone (PEEK) implant improved early outcomes over structural allograft and smooth PEEK in anterior cervical discectomy and fusion (ACDF) procedures.
In the study of 167 patients with degenerative cervical disc disease, those who underwent ACDF using Cohere porous PEEK exhibited significant clinical improvements such as better neck disability scores relative to preoperative scores, better outcomes than other treatments as early as six weeks, and sustained improvements relative to other treatments through 12-months post-op, the company reported. The study also showed that patients treated with smooth PEEK exhibited significant improvements at three months post-procedure. Structural allograft patients began to improve over baseline by six weeks.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.